These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 14598147)

  • 1. Intrahepatic cholangiocarcinoma: macroscopic type and stage classification.
    Yamasaki S
    J Hepatobiliary Pancreat Surg; 2003; 10(4):288-91. PubMed ID: 14598147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma.
    Uenishi T; Yamazaki O; Yamamoto T; Hirohashi K; Tanaka H; Tanaka S; Hai S; Kubo S
    J Hepatobiliary Pancreat Surg; 2005; 12(6):479-83. PubMed ID: 16365823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intrahepatic cholangiocarcinoma: proposal of new macroscopic classification].
    Yamamoto J; Kosuge T; Shimada K; Takayama T; Yamasaki S; Ozaki H; Makuuchi M
    Nihon Geka Gakkai Zasshi; 1993 Nov; 94(11):1194-200. PubMed ID: 8272051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement.
    Shimada K; Sano T; Nara S; Esaki M; Sakamoto Y; Kosuge T; Ojima H
    Surgery; 2009 Apr; 145(4):411-6. PubMed ID: 19303990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes.
    Hirohashi K; Uenishi T; Kubo S; Yamamoto T; Tanaka H; Shuto T; Kinoshita H
    Hepatogastroenterology; 2002; 49(44):326-9. PubMed ID: 11995443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic resection for intrahepatic cholangiocarcinoma: relation to gross tumor morphology.
    Itamoto T; Asahara T; Katayama K; Nakahara H; Fukuda T; Yano M; Hino H; Nakahara M; Dohi K; Shimamoto F
    Hepatogastroenterology; 2001; 48(40):1129-33. PubMed ID: 11490816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological characteristics of intrahepatic cholangiocellular carcinoma presenting intrahepatic bile duct growth.
    Yamamoto Y; Shimada K; Sakamoto Y; Esaki M; Nara S; Ban D; Kosuge T; Ojima H
    J Surg Oncol; 2009 Mar; 99(3):161-5. PubMed ID: 19101954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type.
    Aishima S; Kuroda Y; Nishihara Y; Iguchi T; Taguchi K; Taketomi A; Maehara Y; Tsuneyoshi M
    Am J Surg Pathol; 2007 Jul; 31(7):1059-67. PubMed ID: 17592273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.
    Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Valdegamberi A; Nicoli P; Cappellani A; Malfermoni G; Iacono C
    World J Surg; 2009 Jun; 33(6):1247-54. PubMed ID: 19294467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma.
    Higashi M; Yonezawa S; Ho JJ; Tanaka S; Irimura T; Kim YS; Sato E
    Hepatology; 1999 Dec; 30(6):1347-55. PubMed ID: 10573510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrahepatic peripheral cholangiocarcinoma: mode of spread and choice of surgical treatment.
    Sasaki A; Aramaki M; Kawano K; Morii Y; Nakashima K; Yoshida T; Kitano S
    Br J Surg; 1998 Sep; 85(9):1206-9. PubMed ID: 9752860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type.
    Shibahara H; Tamada S; Higashi M; Goto M; Batra SK; Hollingsworth MA; Imai K; Yonezawa S
    Hepatology; 2004 Jan; 39(1):220-9. PubMed ID: 14752841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between tumor size and mode of spread in mass-forming intrahepatic cholangiocarcinoma.
    Sasaki A; Kawano K; Aramaki M; Ohno T; Tahara K; Kitano S
    Hepatogastroenterology; 2004; 51(55):224-8. PubMed ID: 15011869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma.
    Morimoto Y; Tanaka Y; Ito T; Nakahara M; Nakaba H; Nishida T; Fujikawa M; Ito T; Yamamoto S; Kitagawa T
    J Hepatobiliary Pancreat Surg; 2003; 10(6):432-40. PubMed ID: 14714164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proposal of a new staging system for mass-forming intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery.
    Uenishi T; Ariizumi S; Aoki T; Ebata T; Ohtsuka M; Tanaka E; Yoshida H; Imura S; Ueno M; Kokudo N; Nagino M; Hirano S; Kubo S; Unno M; Shimada M; Yamaue H; Yamamoto M; Miyazaki M; Takada T
    J Hepatobiliary Pancreat Sci; 2014 Jul; 21(7):499-508. PubMed ID: 24519806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors of intrahepatic cholangiocarcinoma after surgical treatment.
    Kinoshita H; Tanimura H; Uchiyama K; Tani M; Onishi H; Yamaue H
    Oncol Rep; 2002; 9(1):97-101. PubMed ID: 11748464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive allelotyping of human intrahepatic cholangiocarcinoma.
    Momoi H; Okabe H; Kamikawa T; Satoh S; Ikai I; Yamamoto M; Nakagawara A; Shimahara Y; Yamaoka Y; Fukumoto M
    Clin Cancer Res; 2001 Sep; 7(9):2648-55. PubMed ID: 11555575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrahepatic cholangiocarcinoma: new insights in pathology.
    Sempoux C; Jibara G; Ward SC; Fan C; Qin L; Roayaie S; Fiel MI; Schwartz M; Thung SN
    Semin Liver Dis; 2011 Feb; 31(1):49-60. PubMed ID: 21344350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinicopathologic significance of the expression of vascular endothelial growth factor-C in intrahepatic cholangiocarcinoma.
    Park BK; Paik YH; Park JY; Park KH; Bang S; Park SW; Chung JB; Park YN; Song SY
    Am J Clin Oncol; 2006 Apr; 29(2):138-42. PubMed ID: 16601431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact of the surgical margin status in hepatectomy for solitary mass-forming type intrahepatic cholangiocarcinoma without lymph node metastases.
    Shimada K; Sano T; Sakamoto Y; Esaki M; Kosuge T; Ojima H
    J Surg Oncol; 2007 Aug; 96(2):160-5. PubMed ID: 17443744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.